Curran Terrie (CIK 1690298) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-28). Recent activity: Buy ARQT (11,148 shares), Sell ARQT (11,148 shares), Buy ARQT (27,052 shares), Sell ARQT (27,052 shares), Buy ARQT (1,072 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-28 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Buy | 11,148 | $83,721 |
| 2026-08-28 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Sell | 11,148 | $279,028 |
| 2026-08-28 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Buy | 27,052 | $233,459 |
| 2026-08-28 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Sell | 27,052 | $677,095 |
| 2026-08-24 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Buy | 1,072 | $8,051 |
| 2026-08-24 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Sell | 1,072 | $27,912 |
| 2026-06-09 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Buy | 5,778 | $0 |
| 2025-06-16 | Arcutis Biotherapeutics, Inc. (ARQT) | Director | Buy | 7,609 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-08-28